Open Access

Erratum to: A commentary on the 2015 Canadian Clinical Practice Guidelines in glutamine supplementation to parenteral nutrition

Critical Care201620:24

https://doi.org/10.1186/s13054-016-1203-y

Received: 19 January 2016

Accepted: 19 January 2016

Published: 25 January 2016

The original article was published in Critical Care 2016 20:7

The author would like to issue an erratum for this article [1], and would like to declare the following competing interests which were inadvertently missed in the original publication.

Competing interests

I declare that I worked as an external freelance scientific consultant for Fresenius Kabi in Chile. My work has been limited to bibliographical analysis in the metabolic field non related with clinical practice. I have not endorsed products of Fresenius Kabi company, particularly Dipeptiven.

Notes

Declarations

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Hematology and Oncology, Department of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

Reference

  1. Leguina-Ruzzi A. A commentary on the 2015 Canadian Clinical Practice Guidelines in glutamine supplementation to parenteral nutrition. Critical Care. 2016;20:7.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© Leguina-Ruzzi. 2016

Advertisement